BioPharma Dive ٢ ديسمبر ٢٠٢٥ Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair
BioPharma Dive ١ ديسمبر ٢٠٢٥ Expanding access in oncology trials: The case for a paired tissue-plasma approach
BioPharma Dive ١ ديسمبر ٢٠٢٥ Specialty pharmacy’s secret weapon: The unsung power of the enrollment form
BioPharma Dive ٢٦ نوفمبر ٢٠٢٥ Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
BioPharma Dive ٢٦ نوفمبر ٢٠٢٥ Otsuka gains approval for first-of-its-kind treatment against rare kidney disease